Riskpilot← Back to searchSign inGet full accessBioRefine Denmark A/S
A/SActiveCVR 41500379Nybrovej 167Manufacture of prepared feeds for farm animals · NACE 1091Est. 20201 employeeswww.biorefine.dk
Revenue 2024
DKK -36,8M
-44% vs 2023
EBITDA margin
103.9%
+43% vs 2023
Equity ratio
-23.2%
Financial strength
Net profit 2024
DKK -41,8M
+44% vs 2023
| Revenue | DKK -36,8M | -44% |
| EBITDA | DKK -38,3M | +43% |
| Net profit | DKK -41,8M | +44% |
| Total assets | DKK 32,1M | -33% |
| Equity | DKK -7,4M | +76% |
| Employees | 1 | — |
Legal name
BioRefine Denmark A/S
CVR number
41500379
Legal form
Aktieselskab
NACE code
1091 · Manufacture of prepared feeds for farm animals
Founded
7. juli 2020
Share capital
DKK 10.007.220
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at drive virksomhed med produktion af græsprotein samt anden virksomhed i forbindelse hermed.
Address
Nybrovej 167
Phone
+4575258622
Email
nybro@biorefine.dk
Website
www.biorefine.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | -4.312 | -29.877 | -65.488 | -36.821 |
| Staff expenses | -11.625 | -6.385 | -0 | -0 |
| EBITDA | -8.453 | -31.718 | -66.812 | -38.271 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -8.453 | -31.718 | -66.812 | -38.271 |
| Net financials | -1.172 | -2.719 | -5.215 | -3.578 |
| Profit before tax | -9.625 | -34.437 | -72.027 | -41.849 |
| Tax | -2.117 | -0 | 2.117 | -0 |
| Net profit | -7.508 | -34.437 | -74.144 | -41.849 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 88.267 | 88.484 | 48.104 | 32.053 |
| Equity | -1.508 | -25.945 | -30.573 | -7.422 |
| Long-term debt | 1.166 | 49.240 | 52.867 | 32.366 |
| Short-term debt | 88.609 | 65.189 | 25.810 | 7.109 |
| Total debt | 89.775 | 114.429 | 78.677 | 39.475 |
EBITDA margin
-3827100000.0%
This company
15.8%
Market median
-24222151999% vs market
20212024
Equity ratio
-23.2%
This company
38.2%
Market median
-161% vs market
20212024
Return on equity
-4184900000.0%
This company
18.4%
Market median
-22744021839% vs market
20212024
Net profit margin
-4184900000.0%
This company
8.1%
Market median
-51665432199% vs market
20212024
Asset turnover
-1.15×
This company
1.12×
Market median
-203% vs market
20212024
Debt / equity
5.32×
This company
0.62×
Market median
-758% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-07 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Chairman | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2020 | |
| Company | 25–33.32% | 25–33.32% | 2020 | |
| Company | 25–33.32% | 25–33.32% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DANSK LANDBRUGS FRØSELSKAB AMBA
BioRefine Denmark A/S Board members of BioRefine Denmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tommy Manly | Chief Executive Officer | 0 companies |
| Jesper Langkilde Pagh | Chairman | 0 companies |
| Peter Michael Larsen Stevns | Board of Directors | 0 companies |
| Troels Møller Olesen | Chairman | 0 companies |
| Morten Petri Jensen | Board of Directors | 0 companies |
| Vagn Balle Hundebøll | Board of Directors | 0 companies |
| Søren Halbye | Board of Directors | 0 companies |
| Klaus Kristian Nielsen | Board of Directors | 0 companies |